Q. Chen, C. Yuan / Tetrahedron 66 (2010) 3707–3716
3715
32
(c 0.87, CHCl3); lit.18: [
CDCl3)
a]
þ92.8 (c 3.36, CHCl3); 1H NMR (300 MHz,
Retention time: (R)-enantioisomer, 51.38 min; (S)-enantioisomer,
D
26
d
: 7.26–7.35 (2H, m), 6.99–7.05 (2H, m), 5.82–5.89 (1H, m),
2.06 (3H, s), 1.52 (3H, d, J¼6 Hz).
47.88 min), [
a]
þ2.4 (c 1.00, CHCl3); 1H NMR (400 MHz, CDCl3)
d:
D
7.72–7.79 (4H, m), 5.26–5.30 (1H, m), 3.47–3.53 (1H, m), 3.22–3.27
(1H, m),1.82 (3H, s),1.34 (3H, d, J¼6 Hz); 13C NMR (100 MHz, CDCl3)
4.6.4. Compound 2d. (R)-Acetic acid 1-naphthalen-2-yl-ethyl ester,
d: 169.52, 138.42, 132.53, 129.65, 129.13, 64.90, 60.61, 20.67, 20.14;
obtained as a colorless liquid, 200 mg, yield: 95%, 99% (HPLC), ee:
IR (film): 3090, 2983, 2936, 1741, 1576, 1473, 1390, 1374, 1317, 1238,
1153, 1129, 1086, 1069, 1044, 1011, 782, 570 cmꢁ1; ESIMS (m/z): 338
(MþNH4)þ; Anal. Calcd for C11H13BrO4S: C, 41.54; H, 4.40. Found: C,
41.13; H, 4.08.
29
99% (using OD column, hexane/iPrOH¼95/5, 0.8 mL/min), [
a
]
þ46
D
20
(c 0.88, CHCl3); lit.19: [
a
]
þ33 (c 1.00, CHCl3); 1H NMR (300 MHz,
D
CDCl3)
d
: 8.08 (1H, d, J¼8 Hz), 7.84–7.88 (1H, m), 7.79 (1H, d,
J¼8 Hz), 7.43–7.61 (4H, m), 6.65 (1H, t, J¼6 Hz), 2.11 (3H, s), 1.70
(3H, d, J¼6 Hz).
4.6.13. Compound 2m. (R)-Acetic acid 2-(4-methoxylphenyl)sul-
fonyl-1-methyl-ethyl ester, obtained as a pale yellow liquid, 96 mg,
yield: 83%, ee: 92% (using AD-H column, hexane/iPrOH¼90/10,
4.6.5. Compound 2e. (R)-Acetic acid 1-cyclohexyl-ethyl ester, obt-
ained as a colorless liquid, 150 mg, yield: 90%, 92% (GC) ee: 99%
0.7 mL/min. Retention time: (R)-enantioisomer, 34.19 min; (S)-
27
24
26
(using RT BDEXM column), [
a]
þ7.2 (c 0.77, CHCl3); lit.20: [
a]
enantioisomer, 32.60 min), [
(300 MHz, CDCl3)
a]
D
þ0.33 (c 1.06, CHCl3); 1H NMR
D
D
þ6.6 (c 2.6, CHCl3); 1H NMR (300 MHz, CDCl3)
d
: 4.69–4.74 (1H, m),
d
: 7.83 (2H, d, J¼9 Hz),7.30 (2H, d, J¼9 Hz), 5.25–
2.02 (3H, s), 1.65–1.76 (5H, m), 1.12–1.43 (4H, m), 1.16 (3H, d,
5.28 (1H, m), 3.89 (3H, s), 3.43–3.51 (1H, m), 3.17–3.24 (1H, m), 1.84
J¼6 Hz), 0.93–1.01 (2H, m).
(3H, s), 1.33 (3H, d, J¼6 Hz); 13C NMR (100 MHz, CDCl3)
d: 169.70,
163.89, 131.12, 130.37, 114.50, 65.25, 61.04, 55.72, 20.86, 20.27; IR
(film): 2983, 2937, 2845, 1741, 1596, 1499, 1374, 1318, 1299, 1260,
1237, 1145, 1089, 1043, 838, 815, 804, 772, 573 cmꢁ1; ESIMS (m/z):
290 (MþNHþ4 ), 295 (MþNaþ). Anal. Calcd for C12H16O5S: C, 53.04; H,
6.03. Found: C, 52.93; H, 5.92.
4.6.6. Compound 2f. (R)-Acetic acid 1-methyl-heptyl ester, obta-
ined as a colorless liquid, 155 mg, yield: 92%, 95% (GC), ee: 96%
27
25
(using RT BDEXM column), [
a]
ꢁ2.3 (c 0.73, CHCl3); lit.21: [
a]
D
D
ꢁ1.9 (c 1.50, EtOH); 1H NMR (300 MHz, CDCl3)
d: 4.86–4.92 (1H, m),
2.03 (3H, s), 1.45–1.59 (2H, m), 1.28–1.33 (8H, m), 1.20 (3H, m), 0.88
(3H, t, J¼6 Hz).
4.6.14. Compound 2n. (R)-Acetic acid 2-(diethoxy-phosphoryl)-1-
methyl-ethyl ester, obtained as a pale yellow liquid, 180 mg, yield:
26
4.6.7. Compound 2g. (R)-Acetic acid 1-methyl-3-phenyl-allyl ester,
obtained as a colorless liquid, 174 mg, yield: 92%, 95% (GC) ee: 92%
80%, ee: 92% (using J-W CYCLOSIL-B column), [
a]
þ8.92 (c 1.00,
D
25
CHCl3); lit.23: [
a]
þ9.7 (c 0.50, CHCl3); 1H NMR (400 MHz, CDCl3)
D
27
20
(using RT BDEXM column), [
a]
þ130 (c 0.73, CHCl3); lit.22: [
a
]
d: 5.17–5.21 (1H, m), 4.08–4.15 (4H, m), 1.99–2.21 (5H, m), 1.32–1.39
D
D
þ80 (c 0.25, CHCl3); 1H NMR (300 MHz, CDCl3)
d
: 7.24–7.39 (5H, m),
(9H, m); 31P NMR (121.5 MHz, CDCl3, H3PO4)
d: 27.07.
6.60 (1H, d, J¼11 Hz), 6.15–6.22 (1H, m), 5.51–5.55 (1H, m), 2.07
(3H, s), 1.41 (3H, d, J¼6 Hz).
4.6.15. Compound 2o. (R)-Acetic acid 2-(dipropoxy-phosphoryl)-1-
methyl-ethyl ester, obtained as a pale yellow liquid, 108 mg, yield:
27
4.6.8. Compound 2h. (R)-3-Acetoxy-butyric acid tert-butyl ester,
obtained as a colorless liquid, 195 mg, yield: 99%, ee: 97% (de-
85%, ee: 90% (determined by 31P NMR), [
a]
þ9.37 (c 1.00, CHCl3);
D
1H NMR (400 MHz, CDCl3)
d: 5.18–5.22 (1H, m), 3.97–4.03 (4H, m),
27
termined by its deacetylation by using RT BDEXM column), [
a
]
1.99–2.21 (5H, m), 1.67–1.72 (4H, m), 1.38 (3H, d, J¼6 Hz), 0.96
D
25
þ5.5 (c 1.06, CHCl3); lit.5m: [
a
]
þ7.59 (c 1.00, CHCl3); 1H NMR
(6H, t, J¼7 Hz); 13C NMR (100 MHz, CDCl3)
d: 170.00, 67.14–67.23
D
(300 MHz, CDCl3)
d
: 5.15–5.32 (1H, m), 2.35–2.55 (2H, m), 1.99
(m), 66.19, 33.26, 31.87, 23.78–23.84 (m), 21.02–21.15 (m), 9.97; 31P
(3H, s), 1.41 (9H, s), 1.24 (3H, d, J¼6 Hz).
NMR (121.5 MHz, CDCl3, H3PO4) d: 27.12; IR (film): 3469,
2969, 2880, 1739, 1373, 1243, 995, 556 cmꢁ1; ESIMS (m/z): 267.0
[MþH]þ; HRMS-ESI: calcd for C11H24O5P(MþH)þ: 267.1357; found:
267.1356.
4.6.9. Compound 2i. (R)-Acetic acid 2-(4-chlorophenyl)sulfonyl-1-
methyl-ethyl ester, obtained as a colorless liquid, 250 mg, yield:
94%, ee: 94% (using AD-H column, hexane/iPrOH¼95/5, 0.7 mL/
26
min), [
a
]
D
þ1.4 (c 1.00, CHCl3); 1H NMR (300 MHz, CDCl3)
d
: 7.85
4.6.16. Compound 2p. (R)-Acetic acid 2-(diisopropoxy-phospho-
(2H, d, J¼9 Hz),7.56 (2H, d, J¼9 Hz), 5.27–5.30 (1H, m), 3.46–3.54
ryl)-1-methyl-ethyl ester, obtained as a pale yellow liquid, 70 mg,
27
(1H, m), 3.20–3.27 (1H, m), 1.82 (3H, s), 1.34 (3H, d, J¼6 Hz).
yield: 70%, ee: >95% (determined by 31P NMR), [
a
]
D
þ10.39 (c 0.60,
20
CHCl3); lit.24: [
a
]
þ11.1 (c 1.80, acetone); 1H NMR (400 MHz,
D
4.6.10. Compound 2j. (R)-Acetic acid 2-phenylsulfonyl-1-methyl-
CDCl3) d: 5.16–5.20 (1H, m), 4.68–4.73 (2H, m), 1.89–2.21 (5H, m),
ethyl ester, obtained as a white solid, mp: 87–89 ꢀC, 85 mg, yield:
1.26–1.37 (15H, m); 31P NMR (121.5 MHz, CDCl3, H3PO4)
d: 25.34.
85%, ee: 95% (using AS column, hexane/iPrOH¼60/40, 0.7 mL/min),
26
[
a]
þ0.24 (c 1.00, CHCl3); lit.5p: [
a
]
D þ0.6 (c 1.50, CHCl3); 1H NMR
4.6.17. Compound 2q. (R)-Acetic acid 2-(dibutoxy-phosphoryl)-1-
D
(300 MHz, CDCl3)
d
: 7.89 (2H, d, J¼7 Hz), 7.64–7.66 (1H, m), 7.56
methyl-ethyl ester, obtained as a pale yellow liquid, 85 mg, yield:
27
(1H, d, J¼7 Hz), 5.28–5.29 (1H, m), 3.46–3.54 (1H, m), 3.20–3.25
75%, ee: 92% (determined by 31P NMR), [
a]
þ9.34 (c 1.00, CHCl3);
D
(1H, m), 1.75 (3H, s), 1.32 (3H, d, J¼6 Hz).
1H NMR (400 MHz, CDCl3)
d: 5.18 (1H, m), 4.00–4.07 (4H, m), 1.95–
2.24 (5H, m), 1.62–1.69 (4H, m), 1.37–1.46 (7H, m), 0.94 (6H, t,
4.6.11. Compound 2k. (R)-Acetic acid 2-(4-methylphenyl)sulfonyl-
J¼8 Hz); 13C NMR (100 MHz, CDCl3)
d: 169.96, 66.16, 65.37
(q, J¼4 Hz), 33.19, 32.40–32.47 (m), 31.79, 20.99–21.15 (m), 18.64,
1-methyl-ethyl ester, obtained as
a
white solid, mp: 64–
65 ꢀC,102 mg, yield: 86%, ee: 93% (using AD-H column,
13.50; 31P NMR (121.5 MHz, CDCl3, H3PO4)
d: 27.44; IR (film): 3468,
26
hexane/iPrOH¼95/5, 0.7 mL/min), [
a
]
þ0.10 (c 1.32, CHCl3); lit.5p
:
2960, 2935, 2875, 1740, 1459, 1373, 1243, 1031, 979, 956, 902,
556 cmꢁ1; ESIMS (m/z): 295.0 (MþH)þ; HRMS-ESI: calcd for
C13H28O5P(MþH)þ: 295.1670; found: 295.1669.
D
[
a]
D þ0.6 (CHCl3); 1H NMR (300 MHz, CDCl3)
d: 7.77–7.80 (2H, m),
7.36–7.39 (2H, m), 5.26–5.28 (1H, m), 3.44–3.53 (1H, m), 3.18–3.25
(1H,m), 2.46 (3H, s), 1.80 (3H, s), 1.34 (3H, d, J¼6 Hz).
4.6.18. Compound 2r. (R)-Acetic acid 1-(diisopropoxy-phospho-
4.6.12. Compound 2l. (R)-Acetic acid 2-(4-bromophenyl)sulfonyl-
1-methyl-ethyl ester, obtained as a colorless liquid, 115 mg, yield:
95%, ee: 95% (using AD-H column, hexane/iPrOH¼95/5, 0.7 mL/min.
ryl)-ethyl ester, obtained as a pale yellow liquid, 215 mg, yield: 88%,
27
ee: >95% (Determined by 31P NMR), [
a
]
D
þ17.4 (c 0.92, CHCl3);
25
lit.23: [
a
]
D
þ20.1 (c 1.70, CHCl3); 1H NMR (400 MHz, CDCl3)
d: